Outcomes with De Novo Sirolimus/Mycophenolate Mofetil (MMF) Versus Tacrolimus/MMF in High-Risk Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction

被引：0
作者：
Centeno, A. [1 ]
Duhart, B., Jr. [1 ]
Krauss, A. [1 ]
Patel, S. [2 ]
Rao, V. [1 ]
Eason, J. [1 ]
机构：
[1] Methodist Univ Hosp UTHSC, Memphis, TN USA
[2] Methodist Hosp, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1312
引用
收藏
页码：412 / 412
页数：1
相关论文
共 50 条
[21]   Improved Growth in Pediatric Kidney Recipients after Early Steroid Withdrawal: Daclizumab, Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) Versus TAC, MMF and Steroids (TWIST Study). [J].
Trompeter, S. ;
Grenda, R. ;
Watson, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 :365-365
[22]   Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen [J].
Sampaio, Edison L. ;
Pinheiro-Machado, Paula G. ;
Garcia, Riberto ;
Felipe, Claudia R. ;
Park, Sung I. ;
Casarini, Dulce E. ;
Moreira, Silvia ;
Franco, Marcello F. ;
Tedesco-Silva, Helio, Jr. ;
Medina-Pestana, Jose O. .
CLINICAL TRANSPLANTATION, 2008, 22 (02) :141-149
[23]   Comparison of four different steroid avoidance protocols in kidney transplanation: Tacrolimus (Tac)/mycophenolate mofetil(MMF) versus tae/sirolimus(SLR) versus cyclosporine(CSA)/mmf versus csajs']jslr. [J].
Kumar, MSA ;
Heifets, M ;
Fyfe, B ;
Moritz, MJ ;
Saeed, MI ;
Parikh, MH ;
Kumar, A .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 :286-287
[24]   ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus [J].
Rummo, Oleg O. ;
Carmellini, Mario ;
Rostaing, Lionel ;
Oberbauer, Rainer ;
Christiaans, Maarten H. L. ;
Mousson, Christiane ;
Langer, Robert M. ;
Citterio, Franco ;
Charpentier, Bernard ;
Brown, Malcolm ;
Kazeem, Gbenga ;
Lehner, Frank .
TRANSPLANT INTERNATIONAL, 2017, 30 (01) :83-95
[25]   REDUCED COMPLICATIONS AFTER EARLY STEROID WITHDRAWAL IN PAEDIATRIC KIDNEY RECIPIENTS: DACLIZUMAB (DAC), TACROLIMUS (TAC) AND MYCOPHENOLATE MOFETIL (MMF) VERSUS TAC, MMF AND STEROIDS (TWIST STUDY) [J].
Watson, A. R. ;
Grenda, R. ;
Trompeter, R. S. .
PEDIATRIC NEPHROLOGY, 2009, 24 (09) :1799-1799
[26]   Outcomes of de novo belatacept versus tacrolimus in kidney recipients of high risk donors [J].
Alameddine, Mahmoud ;
Gaynor, Jeffrey ;
Chen, Linda ;
Moghadamyeghaneh, Zhobin ;
Ciancio, Gaetano ;
Osman, Mohammed ;
Vianna, Rodrigo ;
Burke, George ;
Morsi, Mahmoud ;
Chia, Vincent ;
Kupin, Warren ;
Mattiazzi, Adela ;
Guerra, Giselle .
TRANSPLANTATION, 2016, 100 (07) :S82-S82
[27]   Evaluation of clinical outcomes in kidney transplant recipients receiving rabbit antithymocyte globulin induction and tacrolimus within 7 days post-transplant. [J].
Jackson, John ;
Duhart, Benjamin, Jr. .
PHARMACOTHERAPY, 2014, 34 (10) :E292-E292
[28]   Infectious Complications and Leukopenia Following Alemtuzumab or Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients [J].
Khamash, H. ;
Mannon, R. ;
Hanaway, M. ;
Gaston, R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 :482-482
[29]   Assessment of Induction Antithymocyte Globulin Dose Reduction on Outcomes of De Novo Belatacept Immunosuppression in Kidney Transplant Recipients at Risk for Delayed Graft Function [J].
Ali, M. ;
Wynd, M. A. ;
Patel, A. ;
Ahmed, V. ;
Serur, D. ;
Goldstein, M. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) :S849-S850
[30]   COMPARISON OF LOW DOSE AND VERY LOW DOSE EXTENDED-RELEASE TACROLIMUS / MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS [J].
Narumi, Shunji ;
Watarai, Yoshihiko ;
Goto, Norihiko ;
Hiramitsu, Takahisa ;
Yamamoto, Takayuki ;
Tsujita, Makoto ;
Okada, Manabu ;
Futamura, Kenta ;
Kobayashi, Takaaki .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 :313-313
12345